MYC and cancer: Note, that Ras is frequently constitutively activated by mutations in up-stream regulators in breast cancer [76], and c-myc gene overexpression in basal-like breast cancer (∼ 50%) contributes to cancer progression and is highly associated with poor prognosis [77].